Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1968 2
1969 1
1971 1
1972 1
1973 1
1974 1
1977 3
1978 1
1979 2
1980 1
1981 1
1983 1
1984 3
1985 2
1986 4
1987 3
1988 4
1989 4
1990 5
1991 10
1993 5
1994 7
1995 6
1996 8
1997 8
1998 6
1999 2
2000 7
2001 3
2002 8
2003 13
2004 10
2005 12
2006 8
2007 11
2008 7
2009 6
2010 8
2011 9
2012 11
2013 17
2014 15
2015 14
2016 20
2017 15
2018 11
2019 18
2020 24
2021 15
2022 13
2023 19
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

362 results

Results by year

Filters applied: . Clear all
Page 1
Myeloid Sarcoma: Presentation, Diagnosis, and Treatment.
Almond LM, Charalampakis M, Ford SJ, Gourevitch D, Desai A. Almond LM, et al. Clin Lymphoma Myeloma Leuk. 2017 May;17(5):263-267. doi: 10.1016/j.clml.2017.02.027. Epub 2017 Mar 7. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28342811 Review.
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with acute myeloid leukemia (AML), although in some rare cases it may present in nonleukemic patients. ...
Myeloid sarcoma is an extramedullary tumor of immature granulocytic cells. It is a rare condition, most often associated with …
Histiocytic disorders.
McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, Picarsic J, Ribeiro KB, Allen CE. McClain KL, et al. Nat Rev Dis Primers. 2021 Oct 7;7(1):73. doi: 10.1038/s41572-021-00307-9. Nat Rev Dis Primers. 2021. PMID: 34620874 Free PMC article. Review.
The historic term 'histiocytosis' meaning 'tissue cell' is used as a unifying concept for diseases characterized by pathogenic myeloid cells that share histological features with macrophages or dendritic cells. ...The title of this Primer (Histiocytic disorders) was chosen …
The historic term 'histiocytosis' meaning 'tissue cell' is used as a unifying concept for diseases characterized by pathogenic myeloid …
Myeloid sarcoma: An overview.
Ramia de Cap M, Chen W. Ramia de Cap M, et al. Semin Diagn Pathol. 2023 May;40(3):129-139. doi: 10.1053/j.semdp.2023.04.009. Epub 2023 Apr 17. Semin Diagn Pathol. 2023. PMID: 37149396 Review.
Myeloid Sarcoma (MS) is a high grade, hematological malignancy defined as an extramedullary tumor mass of myeloid blasts with or without maturation that effaces tissue architecture. It is a highly heterogenous condition that represents a variety of myeloid …
Myeloid Sarcoma (MS) is a high grade, hematological malignancy defined as an extramedullary tumor mass of myeloid blast …
Myeloid sarcoma: more and less than a distinct entity.
Loscocco GG, Vannucchi AM. Loscocco GG, et al. Ann Hematol. 2023 Aug;102(8):1973-1984. doi: 10.1007/s00277-023-05288-1. Epub 2023 Jun 7. Ann Hematol. 2023. PMID: 37286874 Free PMC article. Review.
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour mass of myeloid blasts occurring at an anatomical site other than the bone marrow, in most cases concomitant with acute myeloid leukaemia (AML), rarely without …
Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour mass of myeloid blasts occ …
Criteria for Diagnosis and Molecular Monitoring of NPM1-Mutated AML.
Falini B, Dillon R. Falini B, et al. Blood Cancer Discov. 2024 Jan 8;5(1):8-20. doi: 10.1158/2643-3230.BCD-23-0144. Blood Cancer Discov. 2024. PMID: 37917833 Review.
NPM1-mutated acute myeloid leukemia (AML) represents the largest molecular subgroup of adult AML. NPM1-mutated AML is recognizable by molecular techniques and immunohistochemistry, which, when combined, can solve difficult diagnostic problems (including identification of …
NPM1-mutated acute myeloid leukemia (AML) represents the largest molecular subgroup of adult AML. NPM1-mutated AML is recognizable by …
Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C, Tzankov A. Faria C, et al. Pathobiology. 2024;91(1):55-75. doi: 10.1159/000530940. Epub 2023 May 11. Pathobiology. 2024. PMID: 37232015 Free PMC article. Review.
Disease progression in myelodysplastic syndromes (MDS), myelodysplastic-myeloproliferative neoplasms (MDS/MPN), and myeloproliferative neoplasms (MPN), altogether referred to as myeloid neoplasms (MN), is a major source of mortality. Apart from transformation to acute m …
Disease progression in myelodysplastic syndromes (MDS), myelodysplastic-myeloproliferative neoplasms (MDS/MPN), and myeloproliferative neopl …
Gene methylation in gastric cancer.
Qu Y, Dang S, Hou P. Qu Y, et al. Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10. Clin Chim Acta. 2013. PMID: 23669186 Free article. Review.
Myeloid sarcoma.
Shahin OA, Ravandi F. Shahin OA, et al. Curr Opin Hematol. 2020 Mar;27(2):88-94. doi: 10.1097/MOH.0000000000000571. Curr Opin Hematol. 2020. PMID: 31904666 Review.
The significance of cytogenetic and molecular abnormalities in myeloid sarcoma is not completely established, but testing for targetable mutations on myeloid sarcoma cells is feasible, imperative, and may guide treatment decisions. Outcomes in myelo …
The significance of cytogenetic and molecular abnormalities in myeloid sarcoma is not completely established, but testing for …
362 results